Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hypersensitivity Reaction

Free Subscription Articles published in Allergy Asthma Proc Retrieve available abstracts of 124 articles: HTML format

Single Articles

September 2025
1. GOLDEN DBK
   Update in stinging insect hypersensitivity.
   Allergy Asthma Proc. 2025;46:382-387.
   PubMed     Abstract available
   
   
   
2. OZANLI I, Uluc NN, Iskender N, Akin TY, et al
   Food allergy concurrent with atopic dermatitis: Correlation with age of onset and severity.
   Allergy Asthma Proc. 2025;46:e137-e143.
   PubMed     Abstract available
   
   
   
3. TELLI O, Aksu K, Akkale O, Tuglu HC, et al
   The impact of aeroallergen sensitization on bronchial hyperreactivity in adults.
   Allergy Asthma Proc. 2025;46:e151-e156.
   PubMed     Abstract available
   
   
   
4. TEKCAN D, Guler T, Comert M, Artac H, et al
   Comparison of negative predictive values of single- and two-day provocation tests with suspected nonsteroidal anti-inflammatory drug and paracetamol allergy in children.
   Allergy Asthma Proc. 2025;46:e166-e171.
   PubMed     Abstract available
   
   
   
5. KARATAS P, Gulec Koksal Z, Uysal P
   Egg allergy in children: Patterns of consumption of homemade fermented milk products by mothers during pregnancy.
   Allergy Asthma Proc. 2025;46:e144-e150.
   PubMed     Abstract available
   
   
   
6. LEVY DS, Nagase FI, Cheung A, Rodeberg DA, et al
   Quality of life and burden of disease in patients with hereditary angioedema and their caregivers.
   Allergy Asthma Proc. 2025;46:398-405.
   PubMed     Abstract available
   
   
   
7. WALLACE DV
   Pediatric allergen immunotherapy in the United States: Current practice, safety, and unmet needs for long-term and preventive outcomes.
   Allergy Asthma Proc. 2025;46:362-381.
   PubMed     Abstract available
   
   
   
8. ZHANG N, Xie C, Chen J, Chen H, et al
   The lymphocyte-eosinophil to neutrophil-monocyte ratio as a potential composite biomarker associated with asthma exacerbations in adults.
   Allergy Asthma Proc. 2025;46:e157-e165.
   PubMed     Abstract available
   
   
   
9. BELLANTI JA
   Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?
   Allergy Asthma Proc. 2025;46:354-361.
   PubMed     Abstract available
   
   
   
10. BELLANTI JA, Settipane RA
    Artificial intelligence and allergy: Shaping the future of diagnosis and therapy.
    Allergy Asthma Proc. 2025;46:351-353.
    PubMed    
    
    
    
11. HATCHER VR, Caballero MY, Schuldt MM, Adams KE, et al
    Got milk? Enzyme-linked immunosorbent assay analysis of casein proteins in methylprednisolone.
    Allergy Asthma Proc. 2025;46:431-437.
    PubMed     Abstract available
    
    
    
12. YILMAZ D, Yilmaz Topal O, Sengul Emeksiz Z, Dibek Misirlioglu E, et al
    Evaluation of diagnostic tests for suspected hypersensitivity reactions to proton pump inhibitors in children.
    Allergy Asthma Proc. 2025;46:471-477.
    PubMed     Abstract available
    
    
    
13. DAVIS J, Ward ER, Huang X, Staggers KA, et al
    Food allergy referral patterns from 2013-2015 to 2016-2018 at Texas Children's Hospital.
    Allergy Asthma Proc. 2025;46:e172-e175.
    PubMed     Abstract available
    
    
    
14. SELNER GE, Nicolaides RE, Chow TG
    Caregiver perceptions of beta-lactam allergy testing for serum sickness-like reactions.
    Allergy Asthma Proc. 2025;46:478-483.
    PubMed     Abstract available
    
    
    
15. GENIS C, Torun Ozel C, Selmanoglu A, Sengul Emeksiz Z, et al
    Pediatric ondansetron hypersensitivity: Clinical features and a preliminary diagnostic approach.
    Allergy Asthma Proc. 2025;46:e183-e190.
    PubMed     Abstract available
    
    
    
16. GUPTA RS, Yang MS
    Managing food allergies in each stage of life.
    Allergy Asthma Proc. 2025;46:444-449.
    PubMed     Abstract available
    
    
    
17. LARENAS-LINNEMANN D, Mosges R
    In-vivo allergen extract potency is maintained in a sublingual immunotherapy maintenance vial of pollens and mites.
    Allergy Asthma Proc. 2025;46:e176-e182.
    PubMed     Abstract available
    
    
    
18. FLUGT A, Rasmussen HM, Agertoft L, Moller S, et al
    Specific immunoglobulin E for aeroallergens: 0.35 kUA/L cutoff value is too low.
    Allergy Asthma Proc. 2025;46:506-511.
    PubMed     Abstract available
    
    
    
19. MILUSKI T, Bhattarai B, Al-Shaikhly T
    Anaphylaxis related to fluoroquinolones: A disproportionality analysis of the FDA Adverse Event Reporting System data base.
    Allergy Asthma Proc. 2025;46:484-488.
    PubMed     Abstract available
    
    
    
20. WHALLEY D, Balp MM, Naujoks C, Gardner DD, et al
    Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticaria.
    Allergy Asthma Proc. 2025;46:462-470.
    PubMed     Abstract available
    
    
    
21. LANG DM
    Management of chronic urticaria: Treatment options when omalizumab fails.
    Allergy Asthma Proc. 2025;46:455-461.
    PubMed     Abstract available
    
    
    
22. BERNSTEIN DI
    Aeroallergen immunotherapy update: Developments since the third Practice Parameter.
    Allergy Asthma Proc. 2025;46:450-454.
    PubMed     Abstract available
    
    
    
23. ORAK AKBAY N, Ozdel Ozturk B, Doganci A, Celebi Sozener Z, et al
    The value of skin testing with tumor necrosis factor-inhibitors in patients with local and systemic hypersensitivity reactions.
    Allergy Asthma Proc. 2025;46:489-497.
    PubMed     Abstract available
    
    
    July 2025
24. CAKMAK ME, Oztop N
    Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience.
    Allergy Asthma Proc. 2025;46:323-327.
    PubMed     Abstract available
    
    
    
25. LIU N, Ding Y, Hu C, Luo F, et al
    Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2025;46:e125-e136.
    PubMed     Abstract available
    
    
    
26. KNOWLES TR, Nehme KJ, Kim SL, Saltoun CA, et al
    Clinical predictors of breakthrough reactions during initial rapid drug desensitizations to platinum chemotherapeutics.
    Allergy Asthma Proc. 2025;46:328-334.
    PubMed     Abstract available
    
    
    
27. ARSLAN B, Pacaci Cetin G, Seker S, Bozkurt Yilmaz HE, et al
    Omalizumab home injection versus hospital administration in severe asthma: Impact on asthma control.
    Allergy Asthma Proc. 2025;46:274-279.
    PubMed     Abstract available
    
    
    
28. ONALAN T, Colkesen F, Akkus FA, Gerek ME, et al
    Biologic treatment discontinuation in severe asthma: A real-life study on factors influencing clinical remission and physician decision-making.
    Allergy Asthma Proc. 2025;46:287-295.
    PubMed     Abstract available
    
    
    
29. WATERS CD, Cruzan A, Silge R
    Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization.
    Allergy Asthma Proc. 2025;46:335-338.
    PubMed     Abstract available
    
    
    
30. HORMET IGDE M, Korkmaz P, Toprak ID, Eyice Karabacak D, et al
    Idiopathic mast cell activation syndrome in real-life practice: clinical features and management.
    Allergy Asthma Proc. 2025;46:314-322.
    PubMed     Abstract available
    
    
    
31. AYTEKIN F, Efe O, Beyhan N, Gidik E, et al
    Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis.
    Allergy Asthma Proc. 2025;46:280-286.
    PubMed     Abstract available
    
    
    
32. BURCH MO, Rocha DG, Belleze L, Da Silva MJO, et al
    Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy.
    Allergy Asthma Proc. 2025;46:296-303.
    PubMed     Abstract available
    
    
    
33. 
    Abstracts Presented at the Eastern Allergy Conference May 29-June 1, 2025, Palm Beach, Florida.
    Allergy Asthma Proc. 2025;46:339-348.
    PubMed    
    
    
    June 2025
34. CHEN Z, Lin C, Zhang J
    Impact of baseline body mass index on asthma incidence in middle-aged and elderly populations: A prospective analysis from China.
    Allergy Asthma Proc. 2025 Jun 24. doi: 10.2500/aap.2025.46.250040.
    PubMed     Abstract available
    
    
    May 2025
35. LUCCIOLI S, Seabol L
    Anaphylaxis in children: Latest insights.
    Allergy Asthma Proc. 2025;46:168-184.
    PubMed     Abstract available
    
    
    
36. AKTEN HS, Dilek E, Orman M, Mete Gokmen EN, et al
    Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment.
    Allergy Asthma Proc. 2025;46:e71-e81.
    PubMed     Abstract available
    
    
    
37. 
    New England Society of Allergy Spring Meeting Abstracts presented March 28, 2025, Worcester, MA.
    Allergy Asthma Proc. 2025;46:267-268.
    PubMed    
    
    
    
38. YEGIT OO, Gelmez MY, Demir S, Akdeniz N, et al
    Diagnosis of ciprofloxacin hypersensitivity improves by incorporating MRGPRX2 in basophil activation test.
    Allergy Asthma Proc. 2025;46:247-256.
    PubMed     Abstract available
    
    
    
39. YOUNG MC, Banerji A
    Angioedema without urticaria: Diagnosis and management.
    Allergy Asthma Proc. 2025;46:185-191.
    PubMed     Abstract available
    
    
    
40. YILMAZ TOPAL O, Tekgoz N, Kaplan MM, Yigit M, et al
    Evaluation of the frequency of allergic diseases in pediatric patients with juvenile idiopathic arthritis.
    Allergy Asthma Proc. 2025;46:e110-e116.
    PubMed     Abstract available
    
    
    
41. ZHANG W, Cao L, Sun J, Zhang C, et al
    Interaction between asthma and overweight/obesity on cancer results from the National Health and Nutrition Examination Survey 2005-2018.
    Allergy Asthma Proc. 2025;46:e82-e90.
    PubMed     Abstract available
    
    
    
42. GUILARTE M, Lumry WR, Magerl M, Martinez Saguer I, et al
    Garadacimab improves long-term health-related quality of life in patients with hereditary angioedema.
    Allergy Asthma Proc. 2025;46:192-199.
    PubMed     Abstract available
    
    
    
43. GUL O, Bayrak Durmaz MS, Yildiz R, Aytekin F, et al
    Single-bag rapid drug desensitization for chemotherapeutic hypersensitivity reactions: A single-center experience.
    Allergy Asthma Proc. 2025;46:240-246.
    PubMed     Abstract available
    
    
    
44. SANDERS J, Greenhawt M, Oppenheimer J, Anagnostou A, et al
    Value-based care in allergy-immunology: Beyond the quality-adjusted life year.
    Allergy Asthma Proc. 2025;46:165-167.
    PubMed     Abstract available
    
    
    
45. ZHENG K, Wang X
    Early-life risk factors for recurrent wheezing in preschool children: A meta-analysis of 15 cohort studies.
    Allergy Asthma Proc. 2025;46:e98-e109.
    PubMed     Abstract available
    
    
    
46. BELLANTI JA, Settipane RA
    From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention.
    Allergy Asthma Proc. 2025;46:161-164.
    PubMed    
    
    
    
47. STAUBACH P, Craig TJ, Fukuda T, Aygoren-Pursun E, et al
    Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab.
    Allergy Asthma Proc. 2025;46:200-208.
    PubMed     Abstract available
    
    
    
48. GENIS C, Kuzucu FN, Selmanoglu A, Ipek Demir K, et al
    Antibiotic allergy in children: Can the severity and characteristics of the index reaction predict drug provocation test results?
    Allergy Asthma Proc. 2025;46:227-234.
    PubMed     Abstract available
    
    
    
49. SOCOLOVSKY C, Louisias M, Alsulami S, Petty CR, et al
    Cost-effectiveness of school integrated pest management and air filtration in students with asthma.
    Allergy Asthma Proc. 2025;46:257-266.
    PubMed     Abstract available
    
    
    
50. ZURAW BL, Lopez-Gonzalez L, Manjelievskaia J, Winer I, et al
    Adherence and persistence among patients with hereditary angioedema receiving long-term prophylaxis in the United States.
    Allergy Asthma Proc. 2025;46:209-217.
    PubMed     Abstract available
    
    
    
51. BRAVERMAN J, Ellis D, Gavata-Steiger S, Dhas AB, et al
    Analyzing social media conversations to gain insights into the experiences of patients with hereditary angioedema.
    Allergy Asthma Proc. 2025;46:218-226.
    PubMed     Abstract available
    
    
    March 2025
52. KE X, Liu S, Wang X, You J, et al
    Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis.
    Allergy Asthma Proc. 2025;46:e43-e60.
    PubMed     Abstract available
    
    
    
53. ONALAN T, Colkesen F, Gerek ME, Akkus FA, et al
    Rapid drug desensitization in seven patients with delayed hypersensitivity reactions to biologics and targeted therapies: Reason, successes, and failures.
    Allergy Asthma Proc. 2025;46:e70-e77.
    PubMed     Abstract available
    
    
    
54. MAGEN E, Merzon E, Green I, Magen I, et al
    Allergic comorbidities in fibromyalgia.
    Allergy Asthma Proc. 2025;46:e33-e42.
    PubMed     Abstract available
    
    
    
55. MONGKONSRITRAGOON W, Varre A, Beydoun S, Revan R, et al
    Factors associated with treatment response in eosinophilic esophagitis patients: Experience from a pediatric tertiary care center.
    Allergy Asthma Proc. 2025;46:135-143.
    PubMed     Abstract available
    
    
    
56. KAYIKCI H, Damadoglu E, Cihanbeylerden M, Tuccar C, et al
    Clinical characteristics and biological treatment responses of patients with late-onset asthma phenotype.
    Allergy Asthma Proc. 2025;46:109-118.
    PubMed     Abstract available
    
    
    
57. WANG M, Gao X, Zhang L
    Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2025;46:88-97.
    PubMed     Abstract available
    
    
    
58. CAO X, Zhao G, Peng H, Mi Y, et al
    Association between allergic diseases and hypertension: Co-occurrence pattern analysis.
    Allergy Asthma Proc. 2025;46:e61-e69.
    PubMed     Abstract available
    
    
    
59. ASLAN AF, Demir S, Toprak ID, Korkmaz P, et al
    From diagnosis to desensitization in immediate hypersensitivity reactions to both oral and parenteral iron salts.
    Allergy Asthma Proc. 2025;46:152-158.
    PubMed     Abstract available
    
    
    
60. BELLANTI JA, Settipane RA
    Type 2 inflammation: A unifying pathway in allergic diseases and a call to action for the Allergist-Immunologist.
    Allergy Asthma Proc. 2025;46:79-81.
    PubMed    
    
    
    
61. AKKUS FA, Colkesen F, Onalan T, Evcen R, et al
    Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma.
    Allergy Asthma Proc. 2025;46:119-125.
    PubMed     Abstract available
    
    
    
62. ENGELHARDT E, Prince BT, Stukus DR, Messeh E, et al
    To test or not to test: Lessons learned from screening infants for peanut allergy.
    Allergy Asthma Proc. 2025;46:144-151.
    PubMed     Abstract available
    
    
    
63. CONWAY AE, Kartha N, Shaker MS, Davis RS, et al
    Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience.
    Allergy Asthma Proc. 2025;46:82-87.
    PubMed     Abstract available
    
    
    January 2025
64. YUSUFOVA N, Gilbert IA, Trudo F, Barlows T, et al
    Evaluation of a disease-state education program in asthma: Application of the Knowledge-to-Action Framework.
    Allergy Asthma Proc. 2025 Jan 27. doi: 10.2500/aap.2025.46.240112.
    PubMed     Abstract available
    
    
    
65. CHRISTIANSEN SC, Zuraw BL
    Idiopathic non-mast cell angioedema: Treatment insights from global experts.
    Allergy Asthma Proc. 2025;46:38-44.
    PubMed     Abstract available
    
    
    
66. GOTOH M, Maekawa Y, Saito S, Kato N, et al
    Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan.
    Allergy Asthma Proc. 2025;46:59-69.
    PubMed     Abstract available
    
    
    
67. CELIK HI, Guvenir FA, Emeksiz ZS, Misirlioglu ED, et al
    Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis.
    Allergy Asthma Proc. 2025;46:e1-e5.
    PubMed     Abstract available
    
    
    
68. JAROENPUNTARUK V, Volcheck GW
    Perioperative anaphylaxis manifesting as cardiac arrest during cardiac surgery.
    Allergy Asthma Proc. 2025;46:70-75.
    PubMed     Abstract available
    
    
    
69. PAPAIOANNOU AI, Kallieri M, Zervas E, Fouka E, et al
    Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study.
    Allergy Asthma Proc. 2025;46:45-51.
    PubMed     Abstract available
    
    
    
70. PETERSEN MM
    Allergen immunotherapy: How to stay current with USP 797 and practice guidelines.
    Allergy Asthma Proc. 2025;46:26-31.
    PubMed     Abstract available
    
    
    
71. GABBAY JM, Fishman MD, Bajaj BVM, Guenther CS, et al
    Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study.
    Allergy Asthma Proc. 2025;46:e6-e12.
    PubMed     Abstract available
    
    
    
72. BOGUNIEWICZ M
    Atopic dermatitis: Best of guidelines and yardstick.
    Allergy Asthma Proc. 2025;46:19-25.
    PubMed     Abstract available
    
    
    
73. LI D, Sorkhabi S, Cruz I, Foley PL, et al
    Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease.
    Allergy Asthma Proc. 2025;46:e13-e23.
    PubMed     Abstract available
    
    
    
74. MARI D, Henson K, Day W, Mcglynn A, et al
    Health disparities investigated in a primary care penicillin allergy removal pathway.
    Allergy Asthma Proc. 2025;46:52-58.
    PubMed     Abstract available
    
    
    
75. LUMRY WR, Grumach AS, Betschel SD, Radojicic C, et al
    Management of hereditary angioedema attacks by patients on long-term prophylaxis versus on-demand therapy only.
    Allergy Asthma Proc. 2025;46:32-37.
    PubMed     Abstract available
    
    
    November 2024
76. HATCHER VR, Adams KE
    Military accession, retention, and deployment: Defining the role of the allergy consultant.
    Allergy Asthma Proc. 2024;45:404-408.
    PubMed     Abstract available
    
    
    
77. EKE GUNGOR H, Turk M, Yucel MB, Koca SB, et al
    Eating increases disease activity in pediatric patients with symptomatic dermographism.
    Allergy Asthma Proc. 2024;45:e65-e71.
    PubMed     Abstract available
    
    
    
78. 
    Abstracts presented at the Eastern Allergy Conference May 30-June 2, 2024, Palm Beach, Florida.
    Allergy Asthma Proc. 2024;45:461-469.
    PubMed    
    
    
    
79. SHAKER MS
    The use of biologics in food allergy management.
    Allergy Asthma Proc. 2024;45:409-413.
    PubMed     Abstract available
    
    
    
80. DOGAN S, Ertugrul A, Ozer M, Severcan EU, et al
    Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity.
    Allergy Asthma Proc. 2024;45:e81-e86.
    PubMed     Abstract available
    
    
    
81. DENG E, Craig TJ, Nguyen DV, Al-Shaikhly T, et al
    COVID-19 and severe cutaneous allergic reactions to sulfonamides.
    Allergy Asthma Proc. 2024;45:e93-e100.
    PubMed     Abstract available
    
    
    
82. MORITZ G, Becker JH, Ankam JV, Arcoleo K, et al
    Considering different Montreal Cognitive Assessment cutoff scores for older adults with asthma.
    Allergy Asthma Proc. 2024;45:e72-e80.
    PubMed     Abstract available
    
    
    
83. ODIN R, Anderson J, Jacobs J, Jones D, et al
    The utility of shared decision making in the management of hereditary angioedema.
    Allergy Asthma Proc. 2024;45:434-437.
    PubMed     Abstract available
    
    
    
84. POLLOCK J, Watson N, Pittman L, Schwartz D, et al
    Ultrafiltered dog allergen skin test compared with acetone precipitated and conventional dog: A retrospective study.
    Allergy Asthma Proc. 2024;45:453-455.
    PubMed     Abstract available
    
    
    
85. HELLU T, Gomez R, Weiss S, Smith D, et al
    Do commercial dog extracts cross-react with Felis domesticus allergen 1.
    Allergy Asthma Proc. 2024;45:447-452.
    PubMed     Abstract available
    
    
    
86. BELLANTI JA, Settipane RA
    Integrating innovation and shared decision-making in allergy and immunology practice.
    Allergy Asthma Proc. 2024;45:395-397.
    PubMed    
    
    
    
87. ZHENG K, Wang X, Tang L, Chen L, et al
    A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children.
    Allergy Asthma Proc. 2024;45:e101-e110.
    PubMed     Abstract available
    
    
    
88. MULLUR J, Lundberg M, Maurer R, Laidlaw TM, et al
    Dupilumab rapidly improves eustachian tube dysfunction and otologic symptoms in aspirin-exacerbated respiratory disease.
    Allergy Asthma Proc. 2024;45:421-425.
    PubMed     Abstract available
    
    
    
89. HUANG YC, Caldarone L, Sherman C, Deutsch R, et al
    The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis.
    Allergy Asthma Proc. 2024;45:438-446.
    PubMed     Abstract available
    
    
    
90. ANDERSON J, Soteres D, Tachdjian R, Mellor J, et al
    Real-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis.
    Allergy Asthma Proc. 2024;45:426-433.
    PubMed     Abstract available
    
    
    September 2024
91. BELLANTI JA, Settipane RA
    Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT).
    Allergy Asthma Proc. 2024;45:291-293.
    PubMed    
    
    
    July 2024
92. AKTEN HS, Tunakan Dalgc C, Demir M, Okan K, et al
    Early testing and grade of the reaction are affecting factors of skin test positivity in beta-Lactam allergies.
    Allergy Asthma Proc. 2024;45:e23-e30.
    PubMed     Abstract available
    
    
    
93. CAKMAK ME, Bostan OC, Kaya SB, Karakaya G, et al
    Assessment of clinical phenotypic characteristics of patients with angioedema without wheals in a turkish population.
    Allergy Asthma Proc. 2024;45:240-246.
    PubMed     Abstract available
    
    
    
94. SANDOVAL A, Jung Y, Kim I, Sadigh N, et al
    Evaluation of atopic diseases in patients with allergic contact dermatitis.
    Allergy Asthma Proc. 2024;45:262-267.
    PubMed     Abstract available
    
    
    
95. GULTUNA S, Basa Akdogan B, Gonul M, Aydin FN, et al
    Sleep quality in patients with chronic spontaneous urticaria and relation with Orexin-A, leptin, and ghrelin.
    Allergy Asthma Proc. 2024;45:e38-e45.
    PubMed     Abstract available
    
    
    
96. XIE T, Zhong LL
    Association of serum pertussis antibodies with acute asthma attacks in children.
    Allergy Asthma Proc. 2024;45:e54-e61.
    PubMed     Abstract available
    
    
    
97. AYTEKIN GUVENIR F, Sengul Emeksiz Z, Buyuk Yaytokgil S, Toyran M, et al
    Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings.
    Allergy Asthma Proc. 2024;45:e31-e37.
    PubMed     Abstract available
    
    
    
98. KAYIKCI H, Bostan OC, Tuncay G, Cihanbeylerden M, et al
    Efficacy and safety of hymenoptera venom immunotherapy.
    Allergy Asthma Proc. 2024;45:268-275.
    PubMed     Abstract available
    
    
    
99. ANDERSON J, Soteres D, Mellor J, Connolly H, et al
    Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study.
    Allergy Asthma Proc. 2024;45:247-254.
    PubMed     Abstract available
    
    
    
100. KHAN A, Camacho JV, Cummins H, Tahir H, et al
     Not all marketed skin cleansers' pH is optimal for atopic dermatitis.
     Allergy Asthma Proc. 2024;45:284-287.
     PubMed     Abstract available
     
     
     
101. BELLANTI JA, Settipane RA
     Perspectives on allergic diseases: From asthma to food allergy - A continuing challenge for the Allergist-Immunologist.
     Allergy Asthma Proc. 2024;45:215-218.
     PubMed    
     
     
     
102. JIN Z, Wang W, Fineman S, Liu Y, et al
     Leveraging advanced sensors in pollen research.
     Allergy Asthma Proc. 2024;45:e62-e64.
     PubMed    
     
     
     
103. BAKAY OSK, Kacar N, Gul B, Goksin S, et al
     What can be learned from real-world data about chronic spontaneous urticaria?
     Allergy Asthma Proc. 2024;45:255-261.
     PubMed     Abstract available
     
     
     
104. BUYUKTIRYAKI B, Hela F, Ozturk AB, Dursun AB, et al
     Clinical features, severity, and immunological changes during venom immunotherapy in children and adults.
     Allergy Asthma Proc. 2024;45:276-283.
     PubMed     Abstract available
     
     
     
105. BLEECKER E, Blaiss M, Jacob-Nara J, Huynh L, et al
     Real-world effectiveness of dupilumab versus benralizumab and mepolizumab.
     Allergy Asthma Proc. 2024;45:219-231.
     PubMed     Abstract available
     
     
     May 2024
106. STRANZL T, Bernstein DI, Matsuoka T, Durham S, et al
     Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions.
     Allergy Asthma Proc. 2024 May 17. doi: 10.2500/aap.2024.45.240020.
     PubMed     Abstract available
     
     
     
107. GENIS C, Sengul Emeksiz Z, Buyuk Yaylatokgil S, Ginis T, et al
     Successful rapid liposomal amphotericin B desensitization in pediatric case series.
     Allergy Asthma Proc. 2024;45:201-206.
     PubMed     Abstract available
     
     
     
108. BELLANTI JA, Settipane RA
     Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy.
     Allergy Asthma Proc. 2024;45:143-146.
     PubMed    
     
     
     
109. MARI DC, Banks TA
     Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy.
     Allergy Asthma Proc. 2024;45:207-210.
     PubMed     Abstract available
     
     
     
110. KATIAL JM, Hoyte FCL, Khatiwada A, Katial RK, et al
     Allergen skin test responses in broad U.S. asthma population in those with and without rhinitis.
     Allergy Asthma Proc. 2024;45:158-165.
     PubMed     Abstract available
     
     
     
111. WANG K, Zhang Y, Wan L, Li J, et al
     Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure.
     Allergy Asthma Proc. 2024;45:173-179.
     PubMed     Abstract available
     
     
     
112. RADOJICIC C, Anderson J
     Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmas.
     Allergy Asthma Proc. 2024;45:147-157.
     PubMed     Abstract available
     
     
     
113. BRUNETTO S, Gammeri L, Buta F, Gangemi S, et al
     Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts.
     Allergy Asthma Proc. 2024;45:195-200.
     PubMed     Abstract available
     
     
     
114. AYDIN O, Akbay NO, Buyukatalay ZC, Arslan F, et al
     Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease.
     Allergy Asthma Proc. 2024;45:166-172.
     PubMed     Abstract available
     
     
     
115. TALIERCIO MJ, Alnabulsi RK, Uppal PA, Shaw IM, et al
     Metal implant allergy: A retrospective cohort analysis at a university allergy practice.
     Allergy Asthma Proc. 2024;45:186-194.
     PubMed     Abstract available
     
     
     March 2024
116. SHIN S, Jang S, Kim J, Song J, et al
     Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy.
     Allergy Asthma Proc. 2024;45:128-136.
     PubMed     Abstract available
     
     
     
117. BELLANTI JA, Settipane RA
     Allergic diseases in children: A continuing challenge for the Allergist-Immunologist.
     Allergy Asthma Proc. 2024;45:81-83.
     PubMed    
     
     
     
118. BALOH CH, Hsu JT
     Oral immunotherapy with sunflower seed butter and a review of seed allergy.
     Allergy Asthma Proc. 2024;45:137-140.
     PubMed     Abstract available
     
     
     
119. RUDSENSKE NE, Perkins JB
     Assessing severity of COVID-19 and the development of multi system inflammatory syndrome in children (MIS-C) in pediatric patients with atopic disease.
     Allergy Asthma Proc. 2024;45:92-96.
     PubMed     Abstract available
     
     
     
120. NAVALPAKAM A, Thanaputkaiporn N, Aijja C, Mongkonsritragoon W, et al
     Impact of steroids on the immune profiles of children with asthma living in the inner-city.
     Allergy Asthma Proc. 2024;45:100-107.
     PubMed     Abstract available
     
     
     
121. KAZANCIOGLU A, Konuralp I, Sahiner UM, Soyer O, et al
     Understanding of lipid transfer protein sensitization patterns and its clinical significance in children.
     Allergy Asthma Proc. 2024;45:120-127.
     PubMed     Abstract available
     
     
     
122. KELLER L, Perera EK, Bindon B, Khatiwada A, et al
     Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis.
     Allergy Asthma Proc. 2024;45:97-99.
     PubMed     Abstract available
     
     
     
123. PARK M, Yum HY, Bae JM, Lee S, et al
     Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study.
     Allergy Asthma Proc. 2024;45:112-119.
     PubMed     Abstract available
     
     
     
124. BERNSTEIN JA, Wymer LJ, Nye M, Vesper SJ, et al
     The relationship between childhood atopic dermatitis and asthma in an under resourced community.
     Allergy Asthma Proc. 2024;45:108-111.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.